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Abstract
A carbapenem-resistant Klebsiella pneumoniae was isolated from a blood-culture of an inpatient from Libya, hospitalized in the intensive-care
unit of Negrar Hospital, Italy. The clinical isolate carried the following b-lactamase genes, blaTEM-1, blaSHV-11, blaOXA-1, blaCTX-M-15 and
blaOXA-48, respectively. The blaOXA-48 gene was inserted in the Tn1999.2 transposon type, carried on a conjugative, 60-kilobase plasmid,
that presented an L/M backbone, hosted by a multidrug-resistant ST 101 K. pneumoniae strain. Our report highlights the international
transfer of blaOXA-48 gene and the importance of screening measures of multidrug-resistant Enterobacteriaceae.
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Abstract
Klebsiella pneumoniae strains co-producing klebsiella pneumoniae carbapenemase (KPC) and verona integron-encoded metallo-beta-
lactamase (VIM) are frequently isolated in Greece and have also occurred in other European countries. Conventional combined disc tests
exhibit low sensitivity against these emerging pathogens. We have evaluated modiﬁcations of the KPC/Metallo-b-Lactamase Conﬁrmation
kit (ROSCO) exhibiting high diagnostic value against KPC, VIM and KPC + VIM producers. The key changes were the inclusion of additional
combined tablets containing meropenem plus two inhibitors (dipicolinic acid (1000 lg per tablet) for metallo-b-lactamases and a boronic
acid derivative for KPCs) and the replacement of aminophenylboronic acid by phenylboronic acid (400 lg per tablet).
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Abstract
During April 2010 and June 2010, 334 Enterobacteriaceae isolates from 590 participants (outpatients, inpatients, inpatient carers, hospital
workers and members of their households) were collected from faecal samples. Based on b-lactamase pattern, origin of strains and the
relationship between participants, 44 isolates of extended-spectrum b-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae
were selected from 44 participants (in Ngaoundere Protestant Hospital and Ngaoundere Regional Hospital, Cameroon). To determine the
relatedness of bacterial strains, these isolates were ﬁngerprinted using the automated, repetitive-sequenced-based PCR-based DiversiLab
system. Subsequently, E. coli isolates that had undergone DiversiLab analysis were examined with respect to their phylogenetic group and
detection of the ST131 clone to shed light on the epidemiology of these isolates in the Ngaoundere hospitals. The prevalence of faecal
carriage of ESBL-producing Enterobacteriaceae among the study participants was 54.06%. According to participant groups, the prevalence of
faecal carriage was also high (outpatients 45%; inpatients 67%; inpatient carers 57%; hospital workers 44%; and members of their households
46%). Analysis of the molecular epidemiology of ESBL-producing E. coli and K. pneumoniae showed a close relationship of the isolates
between related and non-related individuals. In addition, DiversiLab results of E. coli identiﬁed four related isolates (4/22) from cluster III
belonging to the epidemiologically important clone ST131. Our results highlight the importance of outpatients, inpatients, their carers,
hospital workers and their families as reservoirs of ESBL-producing Enterobacteriaceae
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Abstract
The emergence of carbapenemase-producing Enterobacteriaceae is a rapidly evolving threat worldwide. Here, we report the molecular
characterization of two Klebsiella pneumoniae isolates carrying both blaOXA-181 and blaNDM-1 or blaNDM-5 isolated from epidemiologically
unrelated patients in Singapore. The blaOXA-181 genes were found existing in different genetic environments.
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Abstract
In a prospective study (2009–2011) in healthcare institutions from the Canary Islands (Spain), 6 out of 298 carbapenem non-susceptible
Pseudomonas aeruginosa isolates produced a metallo-b-lactamase: four IMP-15, two VIM-2 (including one IMP-15-positive isolate) and one
VIM-1. Multilocus sequence typing identiﬁed the single VIM-1-producing isolate as clone ST111 and two IMP-15-producing isolates as ST606,
but, strikingly, bacterial re-identiﬁcation revealed that the other three isolates (producing IMP-15 and/or VIM-2) were actually Pseudomonas
putida. Further retrospective analysis revealed a very high prevalence (close to 50%) of carbapenem resistance in this environmental species.
Hence, we report the simultaneous emergence in hospitals on the Canary Islands of P. putida and P. aeruginosa strains producing IMP-15, a
metallo-b-lactamase not previously detected in Europe, and suggest an underestimated role of P. putida as a nosocomial reservoir of
worrying transferable resistance determinants.
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